AbbVie Inc.

NYSE: ABBV · Real-Time Price · USD
206.66
1.98 (0.97%)
At close: Aug 15, 2025, 3:59 PM
206.01
-0.31%
After-hours: Aug 15, 2025, 07:57 PM EDT

AbbVie Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
8.54B 8.61B 5.15B 5.34B 5.99B 4.88B 6.52B 8.69B 7.59B 11.85B 13.42B 12.65B 12.49B 11.55B 7.54B 6.67B 5.17B
Depreciation & Amortization
8.35B 8.39B 8.36B 8.52B 8.64B 8.7B 8.78B 8.75B 8.54B 8.47B 8.29B 8.21B 8.36B 8.52B 8.61B 8.77B 8.13B
Stock-Based Compensation
1.48B 1.42B 872M 821M 782M 747M 754M 750M 678M 671M 668M 677M 729M 692M 699M 726M 803M
Other Working Capital
-3.76B -2.85B -1.11B -1.18B -34M -676M -351M -273M 145M 278M -273M -740M -1.2B -1.49B -1.42B -1.73B -559M
Other Non-Cash Items
4.73B 4.61B 6.13B 6.67B 6.4B 8.61B 8.28B 7.21B 9.23B 6.15B 4.56B 4.78B 3.94B 4.24B 8.85B 8.37B 7.67B
Deferred Income Tax
-1.09B -1.45B -2.07B -2.66B -3.01B -2.89B -2.01B -1.77B -2B -1.93B -2.16B -1.57B -1.06B -898M -1.98B -2.19B -2.35B
Change in Working Capital
-5.61B -2.78B -1.94B -49M 3.89B 2.81B 3.21B 1.91B 192M -258M -2.19B -1.81B -1.64B -1.32B -1.16B -1.9B -764M
Operating Cash Flow
16.4B 18.81B 16.51B 18.64B 22.69B 22.84B 25.51B 25.54B 24.23B 24.94B 22.59B 22.92B 22.81B 22.78B 22.56B 20.45B 18.65B
Capital Expenditures
-1.02B -974M -888M -858M -795M -777M -785M -743M -708M -695M -669M -709M -761M -787M -879M -879M -861M
Cash Acquisitions
-11.47B -20.32B -19.08B -10.94B -10.26B -1.22B -970M -913M -962M -794M -1.56B -1.95B -1.89B -1.9B -1.24B -1.63B -39.8B
Purchase of Investments
-77M -73M -80M -64M -64M -77M -53M -62M -51M -1.44B -1.47B -1.47B -1.51B -119M -87M -85M -64M
Sales Maturities Of Investments
581M 555M 530M 28M 39M 55M 111M 1.52B 1.54B 1.53B 1.47B 83M 95M 98M 149M 161M 1.51B
Other Investing Acitivies
12M -10M -229M -23M -19M 13M 40M 200M 646M 774M 912M 830M 471M 366M 228M 68M 1.44B
Investing Cash Flow
-11.97B -20.82B -19.75B -11.86B -11.1B -2.01B -1.66B -2M 469M -623M -1.32B -3.22B -3.59B -2.34B -1.83B -2.36B -37.77B
Debt Repayment
-4.95B 7.35B 9.32B 9.72B 12.06B -4.15B -9.21B -11.9B -10.9B -12.43B -9.33B -7.83B -11.29B -8.41B -5.93B -5.38B -1.92B
Common Stock Repurchased
-1.34B -1.71B -1.35B -1.34B -1.34B -1.97B -1.97B -1.97B -1.97B -1.49B -1.61B -1.62B -1.62B -934M -1.1B -1.11B -1.12B
Dividend Paid
-11.18B -11.03B -10.9B -10.78B -10.65B -10.54B -10.42B -10.3B -10.18B -10.04B -9.85B -9.66B -9.46B -9.26B -9.05B -8.83B -8.28B
Other Financial Acitivies
187M 172M 135M 8M -285M -562M -809M -1.09B -968M -840M -708M -520M -462M -430M -318M -240M -936M
Financial Cash Flow
-17.29B -5.21B -2.8B -2.39B -211M -17.22B -22.41B -25.26B -24.02B -24.8B -21.51B -19.63B -22.84B -19.04B -16.4B -15.57B -12.25B
Net Cash Flow
-12.89B -7.29B -6.03B 4.37B 11.36B 3.61B 1.46B 238M 613M -545M -350M -25M -3.66B 1.3B 4.29B 2.53B -31.39B
Free Cash Flow
15.38B 17.83B 15.62B 17.78B 21.89B 22.06B 24.73B 24.8B 23.52B 24.25B 21.92B 22.21B 22.05B 21.99B 21.68B 19.57B 17.79B